Outset Medical Q4 revenue $32M (+14% YoY); COO Vazquez retiring Apr 3

Outset Medical, Inc.

2022-FY EPS reported -$3.38 revenue$115,375,000

Q4 revenue $32.0M (+14% YoY); full-year revenue $115.4M (+12.4% YoY).
GAAP gross margin 16.5% (17.1% non-GAAP); operating loss $45.1M.
Tablo installed base grew 54% YoY to ~4,000 systems; 800 home units.
FY 2023 guidance reaffirmed: revenue $140-150M, non-GAAP gross margin ~20%.
COO Martin Vazquez retiring Apr 3, 2023; expected 6-month consulting arrangement.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Martin Vazquez

Chief Operating Officer

OM · Outset Medical, Inc.

Effective: 2023-04-03
Filed: February 13, 2023, 6:59 PM ET

On February 13, 2023, Martin Vazquez informed the Company of his decision to retire from his role as Chief Operating Officer of the Company effective April 3, 2023 to pursue personal opportunities.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Outset Medical, Inc. reported the fourth quarter and full year ended December 31, 2022 results: revenue Revenue for the fourth quarter of 2022 was $32.0 million, net income Net loss was ($41.4) million. Guidance reaffirmed.

Period: the fourth quarter and full year ended December 31, 2022
Revenue: Revenue for the fourth quarter of 2022 was $32.0 million
Net income: Net loss was ($41.4) million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Martin Vazquez departed as Chief Operating Officer at Outset Medical, Inc..

Action: retire
Role: Chief Operating Officer

Exact text from the filing

On February 13, 2023, Martin Vazquez informed the Company of his decision to retire from his role as Chief Operating Officer of the Company effective April 3, 2023 to pursue personal opportunities.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Outset Medical, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-002612

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.